Quinupristin
Systematic (IUPAC) name | |
---|---|
N-{(6R,9S,10R,13S,15aS,18R,22S,24aS)-18- {[(3S)-1-azabicyclo[2.2.2]oct-3-ylthio]methyl}-22-[4-(dimethylamino)benzyl]- 6-ethyl-10,23-dimethyl-5,8,12,15,17,21,24-heptaoxo-13-phenyldocosahydro-12H- pyrido[2,1-f]pyrrolo-[2,1-l][1,4,7,10,13,16] oxapentaazacyclononadecin-9-yl}-3- hydroxypyridine-2-carboxamide | |
Clinical data | |
Pharmacokinetic data | |
Half-life | 3.1 hours |
Identifiers | |
120138-50-3 | |
PubChem | CID 5388937 |
ChemSpider | 4470884 |
ChEMBL | CHEMBL1200649 |
Chemical data | |
Formula | C53H67N9O10S |
1022.24 g/mol | |
SMILES
| |
|
Quinupristin is an antibiotic, often used in combination with dalfopristin under the trade name Synercid. It is active against Gram-positive bacteria, atypical but not Gram negatives. They inhibit protein synthesis of the cells. Quinupristin & dalfopristin are not active against Enterococcus faecalis and they need to be given in combination with other antibacterials for mixed infections which also involve Gram negative organisms.